StonvexLoading…
StonvexStonvexStonvexCore line items from ALB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.14B | $5.38B | $9.62B | $7.32B |
Operating Income | $-367.08M | $-1.78B | $251.88M | $2.47B |
Net Income | $-510.63M | $-1.18B | $1.57B | $2.69B |
EPS (Diluted) | $-5.76 | $-11.20 | $13.36 | $22.84 |
Total Assets | $16.37B | $16.61B | $18.27B | $15.46B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.62B | $1.19B | $889.90M | $1.50B |
Free Cash Flow OCF − CapEx | $692.47M | $-992.65M | $-827.96M | $646.20M |
Shares Outstanding | 117.72M | 117.56M | 117.36M | 117.17M |